. Author manuscript; available in PMC: 2015 Jul 1.

Published in final edited form as: ASAIO J. 2014 Jul-Aug;60(4):391–399. doi: 10.1097/MAT.0000000000000093

Table 2.

Hemodynamic effects (mean ± SD) both with and without a valve.

Baseline No Valve

Contegra valved conduit

MEAN±SD

EXP

PVC25

PVC50

EXP

PVC25

PVC50

P_TCPC

[mm Hg]

14.1±1.3

14.2±1.8

14.2±1.9

14.2±1.3

14.5±1.8

14.7±2.0

P_Liver

15.6±1.6

15.8±2.3

15.3±1.7

15.3±2.2

15.1±2.3

Q_IVC

[Lpm]

2.25±1.6

2.26±2.0

2.29±2.2

2.25±1.5

2.23±1.8

2.26±1.8

Q_HV

0.50±1.0

0.51±1.1

0.53±1.2

0.50±0.9

0.50±1.0

0.52±1.0

Q_svc

1.14±0.3

1.15±0.5

1.15±0.4

1.17±0.5

1.18±0.5

3.39

3.41

3.43

3.40

3.44

Q_{ante IVC}

136.2

143.1

148.2

133.4

133.2

136.6

Q_{retro IVC}

4.34

10.0

13.3

2.0

2.8

4. 5

\frac{Q_{retro IVC}}{Q_{ante IVC}}

[ml/t_R]

3.2%

7.0%

9.0%

1.5%

2.1%

3.3%

Q_{ante HV}

36.4

37.3

44.4

35.8

35.4

39.8

Q_{retro HV}

7.1

9.1

14.2

6.8

6.1

9.7

\frac{Q_{retro HV}}{Q_{ante HV}}

20%

22%

32%

19%

17%

24%

Power Loss

[mW]

24.4

26.0

28.2

21.8

22.3

24.7